Lars Gosta Ekman
Independent Chair EmeritusDr. Lars Gosta Ekman, M.D. Ph.D., was Executive-in-Residence of Warburg Pincus LLC. Dr. Ekman is Executive Partner of Private Equity of Sofinnova Investment, Inc. from April 2024. Dr. Ekman joined the Sofinnova Investment, Inc. in 2008. Dr. Ekman focuses on Life Science. Dr. Ekman was Executive Partner of Private Equity & Board of Director of Sofinnova Investment, Inc. until April 2024. Dr. Ekman is Independent Chairman of the Board of Sophiris Bio, Inc. from September 2012. Dr. Ekman joined the Sophiris Bio, Inc. on November 10, 2010. Dr. Ekman was Executive Chairman of the Board of Sophiris Bio, Inc. until September 2012. Dr. Ekman was Chairman of Sophiris Bio, Inc. from August 16, 2012. Dr. Ekman is Independent Chair Emeritus of Prothena Corporation plc from May 14, 2024. Dr. Ekman joined the Prothena Corporation plc in May 2005. Dr. Ekman was Independent Chairman of Prothena Corporation plc until May 14, 2024. Dr. Ekman is Director of Aeovian Pharmaceuticals, Inc. from 2022. Dr. Ekman was Executive Officer of Pharmacia LLC. Dr. Ekman was Lead Independent Director of InterMune, Inc. Dr. Ekman was employed at InterMune, Inc. from September 21, 2006 to September 29, 2014. Dr. Ekman was Independent Director of ARYx Therapeutics, Inc. Dr. Ekman was employed at ARYx Therapeutics, Inc. from November 2003 to March 08, 2011. Dr. Ekman was Non-Executive Director of Elan Corporation Limited. Dr. Ekman was employed at Elan Corporation Limited until December 07, 2012. Dr. Ekman was Independent Director of Spark Therapeutics, Inc. from May 2014 to December 17, 2019. Dr. Ekman was employed at Spark Therapeutics, Inc. from May 2014 to December 17, 2019. Dr. Ekman was Independent Director of Ocera Therapeutics, Inc. Dr. Ekman was employed at Ocera Therapeutics, Inc. from January 2009 to June 18, 2015. Dr. Ekman was Independent Director of Amarin Corporation plc from May 19, 2022 to December 31, 2022. Dr. Ekman was Independent Chairman of Amarin Corporation plc from January 01, 2014 to May 19, 2022. Dr. Ekman was employed at Amarin Corporation plc from November 03, 2008 to December 31, 2022. Dr. Ekman was Independent Director of Ultragenyx Pharmaceutical Inc. from March 2016. Dr. Ekman joined the Ultragenyx Pharmaceutical Inc. on March 17, 2016. Dr. Ekman was Director of Aderis Pharmaceuticals, Inc. Dr. Ekman was Executive Vice President of Research and Development of UCB Pharma GmbH. Dr. Ekman was Non-Executive Director of CEBIX Inc. Dr. Ekman was Chairman of Poseida Therapeutics, Inc. Dr. Ekman joined the Poseida Therapeutics, Inc. in August 2015. Dr. Ekman was Member of Advisory Board of Columbine Ventures. Dr. Ekman was Chairman of AFYX Therapeutics A/S. Dr. Ekman has M.D. from Göteborgs universitet, Ph.D. in Experimental Biology from Göteborgs universitet.
公司职务
- 公司名称Prothena Corporation plc股票代码PRTA职务Independent Chair Emeritus共事同僚
- GGGene G. KinneyPresident, CEO & Director
- DGDaniel G. WelchIndependent Chairman
- TBTran B. NguyenChief Financial Officer
- BSBrandon S. SmithChief Operating Officer
- WMWagner M. ZagoChief Scientific Officer
- KLKarin L. WalkerChief Accounting Officer & Controller
- RTRichard T. CollierIndependent Director
- SMShane Martin CookeIndependent Director
